Serological and experimental studies in different forms of myasthenia gravis-Reference-Cited by-同舟云学术

Serological and experimental studies in different forms of myasthenia gravis

Published:2018-01-29 Issue:1 Volume:1413 Page:143-153
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Vincent Angela¹,Huda Saif¹,Cao Michelangelo¹,Cetin Hakan¹,Koneczny Inga¹,Rodriguez-Cruz Pedro¹,Jacobson Leslie¹,Viegas Stuart¹,Jacob Saiju¹,Woodhall Mark¹,Nagaishi Akiko¹,Maniaol Angelina¹,Damato Valentina¹,Leite M. Isabel¹,Cossins Judith¹,Webster Richard¹,Palace Jacqueline¹,Beeson David¹

Affiliation:

1. Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital; University of Oxford; Oxford UK

Funder

Watney Trust/Myaware/NIHR (UK)

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nyas.13592/fullpdf

Reference83 articles.

1. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value;Lindstrom;Neurology,1976

2. Myasthenia gravis: passive transfer from man to mouse;Tokya;Science,1975

3. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations;Engel;Mayo Clin. Proc.,1977

4. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis;Sahashi;J. Neuropathol. Exp. Neurol.,1978

5. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation;Drachman;N. Engl. J. Med.,1978

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping current trends and hotspots in myasthenia gravis from 2003 to 2022: a bibliometric analysis;Frontiers in Neurology;2023-12-28

2. Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy;2023-12-20

3. Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence;Neuropsychiatric Disease and Treatment;2023-12

4. Facial-onset sensory and motor neuronopathy with myasthenia gravis: A case report;Medicine;2023-11-17

5. Ravulizumab for the treatment of myasthenia gravis;Expert Opinion on Biological Therapy;2023-03-04